Valeant Surges While Analysts Remain Cautious

Valeant Pharmaceuticals International Inc. sounded an upbeat note about its future profits, sending the drugmaker’s beaten down shares surging even as analysts remain wary. Bloomberg Gadfly's Max Nisen speaks on "Bloomberg Markets: Canada." His opinions are his own. (Source: Bloomberg)

Tocqueville's Groh Expects More Buoyant Gold Market
50:28 - Douglas Groh, Tocqueville Asset Management portfolio manager, discusses the outlook for gold prices with Bloomberg's Julie Hyman and Julia Chatterley on "Bloomberg Markets." (Source: Bloomberg)
  • Hoisington's Hunt Says Long-Term Yields Are Headed Lower
  • 3 Charts That Show Why It's a Good Year for Stock Pickers
  • Why Trump's Shutdown Threat Should Be Taken Seriously